Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Grekova
Cost- Effectiveness of Real Life Asthma Pharmacotherapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
RS2 Cost-Effectiveness of End-Of-Life, Life-Extending Interventions: NICE's Cost-Effectiveness Threshold Explored
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost Effectiveness of Mepolizumab in Adult Asthma Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria
Pediatrics
Child Health
Pediatrics
Perinatology
Cost-Effectiveness of Pharmacotherapy for Children and Adolescents With Attention Dificit Hyperactivity Disorder
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Bayesian Dynamic Model of Asthma in the Real Life
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience
Thorax
Pulmonary
Respiratory Medicine
Pharmacotherapy for Late-Life Depression
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Loss of Asthma Control After Cessation of Omalizumab Treatment: Real Life Data
Postepy Dermatologii I Alergologii
Dermatology
Allergy
Immunology